OBFClass II

Assay, Genotyping, Hepatitis C Virus

21 CFR 866.3170 / Microbiology

OBF is the FDA product code for Assay, Genotyping, Hepatitis C Virus, a class II device type, regulated under 21 CFR 866.3170. FDA's definition for this code reads: "In vitro diagnostic device for qualitative detection and classification of 8 clinically relevant Hepatitis C Virus RNA genotypes". As of 2026-09-10, FDA records hold no 510(k) clearances under this code and no recalls.

Classification record

Product code: OBF
Device name: Assay, Genotyping, Hepatitis C Virus
FDA definition: In vitro diagnostic device for qualitative detection and classification of 8 clinically relevant Hepatitis C Virus RNA genotypes
Regulation: 21 CFR 866.3170
Device class: Class II
Review panel: Microbiology
Submission type: 510(k)
Implant: No
Life sustaining or supporting: No
GMP exempt: No
Third party review eligible: No
Ingested clearances: 0
Ingested recalls: 0

Companies listing this code with FDA

Companies whose registered establishments list this code

Recent clearances

Product code OBF

FDA records hold no clearances under product code OBF.

Recent recalls

Product code OBF

FDA records show no recalls under product code OBF.

MDM coverage of this record lists here, newest first.

About this record

Sourced from the FDA device classification database, ingested from openFDA. The definition, regulation number, device class and review panel are FDA’s own fields, reproduced without editing.

MDM adds the counts: clearances by decision year, the applicants holding the most clearances under this code, recalls that name it, and the registered establishments that list it. Every count is computed from ingested records only.

Data as of 2026-10-05, the FDA export date for this dataset. Page last changed 2026-09-05. View this product code on fda.gov (opens on fda.gov)